|
An-Lu Chen Shun-Ku Lin*
Department of Chinese Medicine, Taipei City Hospital, RenAi Branch. Department of
Health, Taipei City Covernment
|
|
Many patients with breast cancer pursue Traditional Chinese medication (e.g., Chinese medicine compounds containing Ginseng). However, some clinical doctors recommend patients to avoid taking Ginseng since it may enhance cytokinesis of cancer cells. In fact, cell tests revealed that Ginseng can enhance the activity of estrogen receptor of breast cancer cells. As a result, the survival rate of cancer cells is greatly reduced. Furthermore, the data base established by retrospective studies showed that Ginseng did not increase the risk of endometrial carcinoma for those patients with breast cancer who took Tamoxifen. In addition, Ginseng does not cause the increased risk of breast cancer in menopausal women.
【Keywords】Breast cancer, Ginseng, endometrial carcinoma, Ginsenoside, Herbal-drug Interactions
|
96.04 乳癌患者服用人參之安全性探討
